Clinical trial No longer in our active list Phase 4 Interventional Ages 18 to 89 Women only

Using a laxative before surgery for pelvic prolapse in women

Official title: Pre- and Post-operative Compared to Post-operative Only Polyethylene Glycol 3350 for Minimally Invasive Urogynecologic Surgery

Run by University Hospitals Cleveland Medical Center · NCT06159777 · Data updated 2026-05-14

This study is no longer in our active list. It may have stopped recruiting or finished. The details below are as of 2026-05-14 and are kept for reference. Check ClinicalTrials.gov for its current status, or see similar studies below.

This study is testing whether giving a laxative before surgery helps women with pelvic prolapse feel less discomfort during bowel movements after the procedure.

Quick facts

PhasePhase 4
Study typeInterventional
Ages18 Years to 89 Years
SexWomen only
Enrollment74 (estimated)
SponsorUniversity Hospitals Cleveland Medical Center
Academic / other
Drugs / interventionsradiation
Locations1 site (Cleveland, Ohio)
Trial IDNCT06159777 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are women assigned female sex at birth who are scheduled for minimally invasive surgery to correct pelvic organ prolapse.

Probably not a fit

Patients with pre-existing conditions such as irritable bowel syndrome or symptomatic constipation may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial aims to evaluate the effectiveness of administering polyethylene glycol 3350, a laxative, before surgery in women undergoing procedures for pelvic organ prolapse. The study will compare the discomfort experienced during bowel movements after surgery between two groups: one receiving the laxative pre-operatively and the other receiving it post-operatively. Participants will complete questionnaires before and after their surgeries to assess their experiences. The trial is designed as a multi-institution, single-blind, randomized control study to ensure unbiased results.

Why it matters

Potential benefit: If successful, this approach could significantly reduce post-operative bowel discomfort for women undergoing pelvic prolapse surgery.

How similar studies have gone: While the specific use of pre-operative laxatives in this context may be novel, similar studies have shown that pre-operative bowel management can improve post-operative outcomes.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients assigned female sex at birth undergoing an apical prolapse procedure including: sacrocolpopexy, sacrospinous ligament suspension, uterosacral ligament suspension, or colpocleisis. Planned urogynecologic procedure may include hysterectomy, adnexectomy, colporrhaphy, perineorrhaphy, or treatment of stress urinary incontinence.
* Planning to undergo primary procedure as above via minimally invasive route: vaginal or laparoscopic (including robotic-assisted). Including those that have an unplanned conversion intraoperatively of minimally invasive route to open laparotomy.

Exclusion Criteria:

* Diagnosis of irritable bowel syndrome, inflammatory bowel disease, slow transit constipation, obstructed defecation, or symptomatic constipation at time of study screening and recruitment. (Slow transit constipation and obstructed defecation defined as per American Gastroenterological Association 2013 constipation statement. Symptomatic constipation defined as any of the following: Bristol Stool Scale score of 1 or 2, PAC-SYM score greater than 1.0, self-reported 2 or less bowel movements per week.)
* Current use of pharmacologic laxative agent ≥1x/week (prescription or OTC) for the treatment of constipation symptoms
* Allergy or intolerance to polyethylene glycol 3350
* Planning to undergo surgery via laparotomy
* Scheduled for any concurrent non-urogynecologic procedure, ex abdominoplasty
* History of large bowel resection, surgical treatment of constipation, or anal sphincter surgery
* History of sacral neuromodulation
* Current or prior radiation therapy to the abdomen or pelvis
* Current or prior diagnosis of malignancy
* Unable to provide informed consent

Where it's running

  • University Hospitals Cleveland Medical Center
    Cleveland, Ohio, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.